...
首页> 外文期刊>American Journal of Dermatopathology >Prevalence of merkel cell polyomavirus DNA in cutaneous lymphomas, pseudolymphomas, and inflammatory skin diseases
【24h】

Prevalence of merkel cell polyomavirus DNA in cutaneous lymphomas, pseudolymphomas, and inflammatory skin diseases

机译:默克细胞多瘤病毒DNA在皮肤淋巴瘤,假淋巴瘤和炎症性皮肤病中的患病率

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Several groups confirmed Merkel cell polyomavirus (MCPyV) as the likely causative agent of Merkel cell carcinoma. Hematolymphoid disorders are known to be a substantial risk factor for Merkel cell carcinoma, and vice versa. The association between MCPyV and hematologic neoplasms is poorly analyzed, as well as the speculation that lymphocytes may serve as reservoir for MCPyV. Therefore, we investigated the prevalence of MCPyV DNA in primary cutaneous T- and B-cell lymphomas, pseudolymphomas (PLs), and inflammatory skin diseases with dominant lymphocytic infiltrate. We performed a molecular pathology study in 22 tissue samples and 1 blood sample of different cutaneous lymphomas from 19 patients (17 mature T-cell neoplasms, 5 mature B-cell neoplasms, and 1 immature hematopoietic malignancy), 13 PLs from 12 patients, and 25 various inflammatory skin diseases from 23 patients. All tumors were analyzed for the presence of MCPyV DNA by polymerase chain reaction, confirmed by Southern blot hybridization of polymerase chain reaction products. We detected MCPyV DNA in 4 of 23 (17.4%) cutaneous lymphoma tissue samples (3 of 17 mature T-cell neoplasms and 1 of 5 mature B-cell neoplasms), in 2 of 13 (15.4%) PL tissue samples, and 2 of 25 (8%) inflammatory skin conditions (1 drug reaction and 1 erythema multiforme). We conclude that MCPyV DNA is infrequently, but consistently present in lesional tissue from patients with primary cutaneous lymphomas, PLs, and inflammatory skin diseases; prevalence is in the range of 8%-17%. Our results suggest that MCPyV does not play a significant role in the pathogenesis of cutaneous lymphoproliferative disorders.
机译:几个研究小组证实默克尔细胞多瘤病毒(MCPyV)是可能的默克尔细胞癌的病原体。已知血淋巴疾病是默克尔细胞癌的重要危险因素,反之亦然。对MCPyV和血液肿瘤之间的关联分析不多,并且推测淋巴细胞可能充当MCPyV的储库。因此,我们调查了MCPyV DNA在原发性皮肤T细胞和B细胞淋巴瘤,假性淋巴瘤(PLs)和具有优势淋巴细胞浸润的炎症性皮肤病中的患病率。我们对19例患者的22种组织样本和1例血液样本进行了不同皮肤淋巴瘤的分子病理学研究(17例成熟的T细胞肿瘤,5例成熟的B细胞肿瘤和1例未成熟的造血系统恶性肿瘤),12例患者的13例PL来自23位患者的25种各种炎症性皮肤病。通过聚合酶链反应分析所有肿瘤中MCPyV DNA的存在,通过聚合酶链反应产物的Southern印迹杂交证实。我们在23个(17.4%)皮肤淋巴瘤组织样品中的4个(17个成熟T细胞肿瘤中的3个和5个成熟B细胞肿瘤中的1个),13个(15.4%)PL组织样品中的2个和2个中检测到了MCPyV DNA 25(8%)种炎症性皮肤病(1种药物反应和1种多形红斑)。我们得出的结论是,MCPyV DNA很少见,但始终存在于原发性皮肤淋巴瘤,PL和炎性皮肤病患者的病变组织中。患病率在8%-17%的范围内。我们的结果表明,MCPyV在皮肤淋巴增生性疾病的发病机理中没有发挥重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号